Survey: Perception gap divides single-use, stainless camps

It sounds like a generational dispute, with parents only partially believing what the kids tell them. Some 35 percent of stainless steel bioprocess equipment users surveyed say they believe there's a cost advantage to all-disposable systems. Among those who actually use single-use technology, 54 percent are believers.

And nearly twice as many all-disposable users see a process reproducibility advantage over the all-stainless generation (31 to 18 percent), writes Pharmaceutical Technology editor Michelle Hoffman, citing results of an annual survey.

Another finding is that 20 percent of the stainless crowd sees increased contamination risk in all-disposable systems. Among the single-use users--zero percent.

- see the editorial

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.